Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridine. 1990

W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Some 3'- and 5'-[[(alkylamino)ethyl]glycyl] esters of 5-bromo-2'-deoxyuridine were prepared and evaluated in vitro as progenitors of the parent alcohol. The esters proved to be relatively stable at low pH but released 5-bromo-2'-deoxyuridine cleanly at rates which were pH and structure dependent. These basic esters are examples of cyclization-activated prodrugs in which generation of active drug is not linked to enzymatic cleavage but rather results from an intramolecular cyclization-elimination reaction.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
April 1968, The New England journal of medicine,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
November 2007, Molecules (Basel, Switzerland),
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
January 1996, Acta oncologica (Stockholm, Sweden),
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
January 2012, Photochemistry and photobiology,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
August 2002, Journal of chemotherapy (Florence, Italy),
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
March 2005, Bioorganic & medicinal chemistry letters,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
September 1973, Biochemistry,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
October 1989, Pharmaceutical research,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
August 1992, Pharmaceutical research,
W S Saari, and J E Schwering, and P A Lyle, and S J Smith, and E L Engelhardt
May 2000, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!